Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

In order to improve communication between doctors and patients, researchers have now developed visual aids to help patients ...

Wetherby-based Pabasso, which provides support and mentorship for managing directors and CEOs in Yorkshire, has hired Carlos Horner.

Spasmodic dysphonia impacts about 50,000 people in North America. Here's what to know about what causes spasmodic dysphonia ...

Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...

Carlos Horner joins Wetherby-based Pabasso Associate Director and board chair, in a dual role that will see him work on expanding the reach of Pabasso as well as forming his own peer support board of ...

The Mining Software Market is growing rapidly due to the rise in automation, digital technologies, and data analytics in mining operations.Pune, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Mining Software ...

I Herantis Pharma Plc ("Herantis"), a company developing disease-modifying therapies for Parkinson’s disease, is pleased to announce an ...

Diamandis, a graduate of Harvard Medical School, also chairs the $101 Million XPRIZE Healthspan which has over 600 teams ...

Only a tiny percentage of people addicted to alcohol or drugs take medication for it. Why not? It's complicated, but the ...

Study examines the effect of TP53 mutations on outcomes in MDS patients receiving haploidentical haematopoietic stem cell ...